International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 1
January-February 2026
Indexing Partners
Review for enhancing Cancer cell Apoptosis Using withania Somnifera -Based Nano-particles
| Author(s) | Ms. Ekta Verma, Mr. Gaurav Bawniya |
|---|---|
| Country | India |
| Abstract | Cancer treatment remains challenging due to the ability of cancer cells to avoid programmed cell death and grow uncontrollably. Conventional chemotherapy is effective but often causes serious damage to healthy cells. Because of this, plant-based compounds are being studied as safer alternatives. Withania somnifera (Ashwagandha) is a medicinal plant known for its anticancer compound, withaferin A. However, its clinical use is limited because of poor solubility, low bioavailability, and instability in the body. Nano-based drug delivery systems have been developed to overcome these limitations. Nanoformulations of Withania somnifera improve drug stability, enhance cellular uptake, and allow controlled release at tumor sites. Several studies show that these nanoformulations promote apoptosis in cancer cells through increased reactive oxygen species production, mitochondrial damage, activation of caspase enzymes, and regulation of apoptosis-related genes. Importantly, these nano-systems show selective toxicity toward cancer cells while causing minimal harm to normal cells. This makes Withania somnifera-based nanoformulations a promising approach for future cancer therapy. |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 1, January-February 2026 |
| Published On | 2026-01-30 |
| DOI | https://doi.org/10.36948/ijfmr.2026.v08i01.67441 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.